Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients
Authors
Keywords
-
Journal
Molecular Oncology
Volume 12, Issue 1, Pages 48-57
Publisher
Wiley
Online
2017-10-24
DOI
10.1002/1878-0261.12147
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients
- (2016) Esther A. Reijm et al. BMC CANCER
- Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer
- (2016) Tommaso De Marchi et al. DRUG DISCOVERY TODAY
- PlasmaESR1Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer
- (2016) Charlotte Fribbens et al. JOURNAL OF CLINICAL ONCOLOGY
- Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery
- (2016) Jérôme Alexandre Denis et al. Molecular Oncology
- Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant
- (2016) Jill M. Spoerke et al. Nature Communications
- Clinical significance of monitoring ESR1 mutations in circulating cell-free DNA in estrogen receptor positive breast cancer patients
- (2016) Takashi Takeshita et al. Oncotarget
- Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
- (2016) Howard I. Scher et al. JAMA Oncology
- Gene expression profiles of circulating tumor cells versus primary tumors in metastatic breast cancer
- (2015) Wendy Onstenk et al. CANCER LETTERS
- ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients
- (2015) D. Chu et al. CLINICAL CANCER RESEARCH
- Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients
- (2015) P. Wang et al. CLINICAL CANCER RESEARCH
- Noninvasive Detection of Activating Estrogen Receptor 1 (ESR1) Mutations in Estrogen Receptor-Positive Metastatic Breast Cancer
- (2015) D. S. Guttery et al. CLINICAL CHEMISTRY
- Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells
- (2015) Wendy Onstenk et al. EUROPEAN UROLOGY
- Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer
- (2015) Gaia Schiavon et al. Science Translational Medicine
- Droplet digital polymerase chain reaction assay for screening of ESR1 mutations in 325 breast cancer specimens
- (2015) Takashi Takeshita et al. Translational Research
- Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
- (2015) Emmanuel S. Antonarakis et al. JAMA Oncology
- Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients
- (2014) B. Mostert et al. ANNALS OF ONCOLOGY
- Emergence of Constitutively Active Estrogen Receptor- Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer
- (2014) R. Jeselsohn et al. CLINICAL CANCER RESEARCH
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
- (2014) D. A. Haber et al. Cancer Discovery
- Endocrine therapy: is the first generation of targeted drugs the last?
- (2013) K. I. Pritchard JOURNAL OF INTERNAL MEDICINE
- ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
- (2013) Weiyi Toy et al. NATURE GENETICS
- Activating ESR1 mutations in hormone-resistant metastatic breast cancer
- (2013) Dan R Robinson et al. NATURE GENETICS
- mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients
- (2011) A. M. Sieuwerts et al. CLINICAL CANCER RESEARCH
- Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR
- (2009) Anieta M. Sieuwerts et al. BREAST CANCER RESEARCH AND TREATMENT
- Oestrogen receptor splice variants in the pathogenesis of disease
- (2009) Siân E. Taylor et al. CANCER LETTERS
- Estrogen Receptors Alpha (ESR1) and Beta (ESR2) Are Expressed in Circulating Human Lymphocytes
- (2008) JOHN K. SCARIANO et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started